Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

496 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Recruiting

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

NCT07268638

Conditions
Chronic Disease, Disease Attributes, Female Urogenital Diseases, +17 more
Locations
  • Investigator Site #2 Chula Vista, California, United States
  • Investigator Site #14 Los Angeles, California, United States
  • Investigator Site #12 San Dimas, California, United States
  • Investigator Site #13 Arvada, Colorado, United States
View all 23 locations
View Trial Details
Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

NCT06711887

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Circuit Clinical Orchard Park, New York, United States
  • Novartis Investigative Site Vitória, Espírito Santo, Brazil
  • Novartis Investigative Site Salvador, Estado de Bahia, Brazil
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
View all 41 locations
View Trial Details
Recruiting

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

NCT06975787

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Baylor College of Medicine Houston, Texas, United States
  • Centre Hospitalier Universitaire (CHU) Bordeaux Bordeaux, New Aquitaine, France
  • University Hospital Regensburg Regensburg, Bavaria, Germany
View all 18 locations
View Trial Details
Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

NCT06897930

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Stanford, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Recruiting

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

NCT07053800

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • State University of New York Upstate Medical Center (SUNY) Syracuse, New York, United States
  • Texas Transplant Institute San Antonio, Texas, United States
  • University General Hospital ATTIKON Athens, Greece
  • University General Hospital of Patras Pátrai, Greece
View Trial Details
Recruiting

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

NCT06527872

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Columbus, Ohio, United States
  • GSK Investigational Site Hixson, Tennessee, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

NCT05039619

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Loma Linda University health Loma Linda, California, United States
  • UCSF Benioff Childrens Hospital San Francisco, California, United States
  • Children's Hospital Colorado, Anchutz Medical Campus Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
View all 42 locations
View Trial Details

Related conditions